A Study Based on Medical Records That Looks at the Duration of Use of Two Types of Inhalers With Different Medicines in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Boehringer Ingelheim
Age
1–40
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
\-
You may not be if
Aged \<40 years
Enrolment with medical and pharmacy coverage prior to the cohort entry \< 180 days
Never had COPD diagnosis on the cohort entry date or prior to cohort entry
A record for dispensed Olodaterol/Tiotropium Bromide delivered with Respimat inhalator or Umeclidinium/Vilanterol delivered with the Ellipta Inhaler during the 180-day baseline prior to cohort entry
Diagnosis of asthma any time prior to cohort entry
Diagnosis of lung cancer any time prior to cohort entry
Diagnosis of lung transplant any time prior to cohort entry
Clareo Health | A Study Based on Medical Records That Looks at the Duration of Use of Two Types of Inhalers With Different Medicines in Patients With Chronic Obstructive Pulmonary Disease (COPD)
